Mycenax Biotech Inc. (TPEX:4726)
20.70
-0.30 (-1.43%)
Nov 6, 2026, 1:30 PM CST
| Market Cap | 4.29B -36.6% |
| Revenue (ttm) | 815.87M +12.2% |
| Net Income | -381.91M |
| EPS | -1.84 |
| Shares Out | 207.04M |
| PE Ratio | n/a |
| Forward PE | n/a |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 389,369 |
| Open | 20.05 |
| Previous Close | 21.00 |
| Day's Range | 19.95 - 21.00 |
| 52-Week Range | 20.00 - 37.00 |
| Beta | 0.48 |
| Analysts | n/a |
| Price Target | n/a |
| Est. Earnings | Nov 12, 2026 |